🔎 Trials Near Me

Domov › Ulcerativni kolitis › Louisiana

Klinične študije za Ulcerativni kolitis v Louisiana

15 študij za Ulcerativni kolitis išče udeležence na lokacijah v Louisiana.

Mesta v Louisiana

Uradno besedilo študije (angleško)

Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis

  • Gastro Group and Endocenter: Mandeville, la /ID# 284186, Mandeville
  • Metropolitan Gastroenterology Associates - Metairie /ID# 283922, Metairie
  • Willis-Knighton Medical Center /ID# 280572, Shreveport
Vključevanje udeležencevFaza 2
Starost 18–75 · Vsi spoli · Posodobljeno 2. okt. 2026 · NCT07697456

A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting

  • Baton Rouge General Medical Center - Bluebonnet Campus, Baton Rouge
  • Combined Gastro LLC, Lafayette
  • GI Alliance, Metairie
Vključevanje udeležencevFaza 4
Starost 18–80 · Vsi spoli · Posodobljeno 30. sep. 2026 · NCT06581328

A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis

  • Clinical Trials Management, LLC, Metairie
Vključevanje udeležencevFaza 2
Starost 18–75 · Vsi spoli · Posodobljeno 30. sep. 2026 · NCT06598943

A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis

  • Site 035, Marrero
Vključevanje udeležencevFaza 2
Starost 18–75 · Vsi spoli · Posodobljeno 29. sep. 2026 · NCT07012395

A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis

  • Site US-008, Baton Rouge
  • Site US-011, Mandeville
Vključevanje udeležencevFaza 2
Starost 18–75 · Vsi spoli · Posodobljeno 29. sep. 2026 · NCT07845487

A Study to Evaluate Efficacy and Safety of MK-8690 in Participants With Moderately to Severely Active Ulcerative Colitis (MK-8690-002)

  • Tulane University School of Medicine-Gastroenterology and Hepatology ( Site 1073), New Orleans
Vključevanje udeležencevFaza 2
Starost 18–75 · Vsi spoli · Posodobljeno 28. sep. 2026 · NCT07463183

A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis

  • Delta Research Partners, LLC, West Monroe
Vključevanje udeležencevFaza 3
Starost 12 in več · Vsi spoli · Posodobljeno 25. sep. 2026 · NCT07196748

Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study

  • Care Access - New Iberia, New Iberia
  • Louisiana Research Center, Shreveport
Vključevanje udeležencevFaza 3
Starost 18–70 · Vsi spoli · Posodobljeno 24. sep. 2026 · NCT06937086

LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis

  • GI Alliance - Gastro Group and Endocenter - Mandeville, Mandeville
Vključevanje udeležencevFaza 2
Starost 18–80 · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT07415044

A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)

  • GI Alliance, Metairie
  • Tulane University, New Orleans
Vključevanje udeležencevFaza 4
Starost 18–65 · Vsi spoli · Posodobljeno 21. sep. 2026 · NCT06095128

A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis

  • GI Alliance - Baton Rouge - Site Number: 8400129, Baton Rouge
  • Texas Digestive Disease Consultants, PLLC d/b/a GI Alliance - Mandeville - Site Number: 8400128, Mandeville
  • Delta Research Partners - Site Number: 8400087, Monroe
Vključevanje udeležencevFaza 3
Starost 16–80 · Vsi spoli · Posodobljeno 15. sep. 2026 · NCT07185009

A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis

  • Gastroenterology Clinic of Acadiana, Lafayette
Vključevanje udeležencevFaza 3
Starost 18 in več · Vsi spoli · Posodobljeno 28. avg. 2026 · NCT07577856

An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis

  • GI Alliance - Baton Rouge - Site Number: 8400129, Baton Rouge
  • Tandem Intermediate, LLC - Houma -Site Number: 8400034, Houma
  • GastroGroup - Site Number: 8400128, Mandeville
  • in še 4
Vključevanje udeležencevFaza 3
Starost 16–80 · Vsi spoli · Posodobljeno 20. avg. 2026 · NCT07184996

A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease

  • Mirador Therapeutics Selected Site, Lafayette
  • Mirador Therapeutics Selected Site, Marrero
  • Mirador Therapeutics Selected Site, Shreveport
Vključevanje udeležencevFaza 2
Starost 18–80 · Vsi spoli · Posodobljeno 12. mar. 2026 · NCT07113522

Study of Efficacy and Adherence to Subcutaneous vs. Intravenous Vedolizumab in Patients With Inflammatory Bowel Disease Using a Novel Remote MONITORing Intervention

  • Tulane University, New Orleans
Vključevanje udeležencevOpazovalna študija
Starost 18 in več · Vsi spoli · Posodobljeno 8. maj 2025 · NCT06750731

Vir: ClinicalTrials.gov, podatki pridobljeni 5. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.